Tissue Regenix Group (TRX)

 

TRX Share PerformanceMore

52 week high22.500 18/03/16
52 week low12.700 18/01/16
52 week change 2.000 (11.94%)
4 week volume2,124,096 02/09/16

Latest NewsMore

Notice of Interim Results

RNS Number: 0087L Tissue Regenix Group PLC 28 September 2016 Tissue Regenix Group plc Notice of Interim Results Leeds, 28 September 2016 - Tissue Regenix Group (AIM:TRX) ("Tissue Regenix" or "The Group") the regenerative medical devices company today gives notice that it will announce its interim results for the six months ending 31 July 2016, on Wednes...

Edison research outlook on Tissue Regenix

Edison has issued research outlook on Tissue Regenix. It says: "Tissue Regenix's (TRX) investment story is built on dCELL, ...

Edison issues outlook on Tissue Regenix

RNS Number: 9785J Tissue Regenix Group PLC 15 September 2016 London, UK, 15 September 2016 Edison issues research outlook on Tissue Regenix (TRX) Tissue Regenix's (TRX) investment story is built on dCELL, a versatile regenerative medical technology and its potential applications across the subsectors: cardiac, wound care and orthopaedics. The cardiac division...

Tissue Regenix extends DermaPure's Medicare coverage

Tissue Regenix has gained Medicare coverage in an additional 10 States covered by Medicare jurisdiction National Governm...

DermaPure? Medicare coverage in further 10 States

RNS Number: 6258I Tissue Regenix Group PLC 01 September 2016 Tissue Regenix Group plc DermaPure Medicare coverage in further 10 States Leeds, 1 st September 2016 - Tissue Regenix Group (AIM:TRX) ("Tissue Regenix" or "The Group") the regenerative medical devices company announces that effective from today it has gained Medicare coverage in an addition...

Hardman & Co Research Report on: Tissue Regenix

RNS Number: 0513G Tissue Regenix Group PLC 03 August 2016 Hardman Research: Major progress in orthopaedics Major progress towards orthopaedics approvals: Tissue Regenix is now in the commercialisation phase having validated its dCELL technology to produce 'like-for-like' tissue specific, structure-preserving scaffolds for use in multiple clinical settings. Derm...

Edison research outlook on Tissue Regenix (TRX)

RNS Number: 5212F Tissue Regenix Group PLC 28 July 2016 London, UK, 28 July 2016 Edison issues research outlook on Tissue Regenix (TRX) Tissue Regenix's (TRX) investment story is built on dCELL, a versatile regenerative medical technology, and its potential across the subsectors: wound care, orthopaedics and cardiac implants. Orthopaedics holds significant pro...

TR1- NOTIFICATION OF MAJOR INTEREST IN SHARES

RNS Number: 4579E Tissue Regenix Group PLC 18 July 2016 TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii Tissue Regenix Group plc 2 Reason for the notification (please tick the appropriate box or boxes): An acquisition or disposal of voting rights X A...

Fundamental DataMore

EPS-1.27
Dividend yield0 %

Equity Research (TRX)

edison investment research
Tissue Regenix Group Plc
28/07/2016
Tissue Regenix’s (TRX) investment story is built on dCELL, a versatile regenerative medical technology, and its potential across the subsectors: wound care, orthopaedics and cardiac implants....
edison investment research
Tissue Regenix Group Plc
22/03/2016
Tissue Regenix’s (TRX’s) investment case is built on dCELL, a patented decellularised tissue scaffold. Wound care is a main driver for TRX’s growth and recent announcements demonstrate progress on...
hardman & co
Tissue Regenix Group Plc
26/01/2016
Tissue Regenix is no longer an R&D play. Its dCELL® technology enables production of ‘like-for-like’ tissue specific, structure-preserving scaffolds that have been validated in multiple clinical...

Latest discussion posts More

  • A couple of weeks old

    Found this article on Yahoo Finance : - Tissue Regenix Group plc: DermaPure? - Two Peer Reviewed Clinical Papers ...
    27-Sep-2016
    theprior
  • Edison

    Research note values TRX at ...
    16-Sep-2016
    theprior
  • Re: RNS

    Don't worry Mr P - I am hoping October will see the release of the interim results - we can see what has really gone on. See your hungry over on the SCE board as well - now ...
    1-Sep-2016
    swisspaul

Users' HoldingsMore

Users who hold Tissue Regenix Group also hold..
LLOYDS GRP.32%
BP27%
TESCO23%
SIRIUS MINERALS22%
AVIVA16%

Codes & Symbols

ISINGB00B5SGVL29
SymbolsTRX, LSE:TRX, TRX.L, TRX:LN, LON:TRX, XLON:TRX